URGENT: This Altcoin Opportunity Won’t Wait – Act Now

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

Carl Dambkowski Biography and Net Worth

Insider of Apogee Therapeutics

Carl Dambkowski, M.D., has served as Chief Medical Officer since September 2022. He also serves on the Board of Oruka Therapeutics, Inc. Prior to joining Apogee, Dr. Dambkowski served as a strategic and clinical leader for a variety of companies. He was part of the core teams that brought TRUSELTIQ (infigratinib) and NULIBRY (fosdenopterin) through regulatory review and FDA approval at QED Therapeutics and Origin Biosciences. He also served as an Associate at McKinsey & Company, where he advised biotech and pharmaceutical companies across the world on a range of research and development activities and co-founded Novonate, Inc., a private medical device company focused on building life-saving devices for neonates. Dr. Dambkowski trained as a physician at Stanford University, where he received his M.D. with a concentration in bioengineering. He also holds an M.A. from Columbia University and a B.A. from Stanford University. The father of two and avid runner, he has run a sub 6-minute mile while pushing his daughter in a stroller.

What is Carl Dambkowski's net worth?: The estimated net worth of Carl Dambkowski is at least $12.31 million as of December 11th, 2024. Dr. Dambkowski owns 258,073 shares of Apogee Therapeutics stock worth more than $12,312,663 as of December 21st. This net worth estimate does not reflect any other assets that Dr. Dambkowski may own. Additionally, Dr. Dambkowski receives an annual salary of $870,830.00 as Insider at Apogee Therapeutics. Learn More about Carl Dambkowski's net worth.
How old is Carl Dambkowski?: Dr. Dambkowski is currently 38 years old. There are 5 older executives and no younger executives at Apogee Therapeutics. The oldest executive at Apogee Therapeutics is Dr. Rebecca Dabora Ph.D., Chief Development Officer, who is 64 years old. Learn More on Carl Dambkowski's age.
What is Carl Dambkowski's salary?: As the Insider of Apogee Therapeutics, Inc., Dr. Dambkowski earns $870,830.00 per year. The highest earning executive at Apogee Therapeutics is Dr. Michael Thomas Henderson M.D., CEO & Director, who commands a salary of $1,170,000.00 per year. Learn More on Carl Dambkowski's salary.
How do I contact Carl Dambkowski?: The corporate mailing address for Dr. Dambkowski and other Apogee Therapeutics executives is 221 Crescent Street, Building 17 Suite 102b, Waltham, MA 02453, United States. Apogee Therapeutics can also be reached via phone at 650-394-5230 and via email at [email protected]. Learn More on Carl Dambkowski's contact information.
Has Carl Dambkowski been buying or selling shares of Apogee Therapeutics?: During the last ninety days, Carl Dambkowski has sold $1,297,434.65 in shares of Apogee Therapeutics stock. Most recently, Carl Dambkowski sold 4,540 shares of the business's stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $48.76, for a transaction totalling $221,370.40. Following the completion of the sale, the insider now directly owns 258,073 shares of the company's stock, valued at $12,583,639.48. Learn More on Carl Dambkowski's trading history.
Who are Apogee Therapeutics' active insiders?: Apogee Therapeutics' insider roster includes Carl Dambkowski (Insider), Jane Henderson (CFO), and Michael Henderson (CEO). Learn More on Apogee Therapeutics' active insiders.
Are insiders buying or selling shares of Apogee Therapeutics?: In the last year, Apogee Therapeutics insiders bought shares 1 times. They purchased a total of 20,000 shares worth more than $990,800.00. In the last year, insiders at the sold shares 14 times. They sold a total of 215,530 shares worth more than $10,352,408.50. The most recent insider tranaction occured on December, 12th when Director Mark C Mckenna bought 20,000 shares worth more than $990,800.00. Insiders at Apogee Therapeutics own 36.1% of the company. Learn More about insider trades at Apogee Therapeutics.
Information on this page was last updated on 12/12/2024.

Carl Dambkowski Insider Trading History at Apogee Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/11/2024	Sell	4,540	$48.76	$221,370.40	258,073
12/4/2024	Sell	6,665	$46.07	$307,056.55	260,798
11/6/2024	Sell	6,665	$59.12	$394,034.80	267,463
10/2/2024	Sell	6,665	$56.26	$374,972.90	274,128
9/4/2024	Sell	6,665	$47.56	$316,987.40	280,793
8/7/2024	Sell	7,335	$40.67	$298,314.45	287,458
7/3/2024	Sell	5,995	$37.60	$225,412.00	294,793

Carl Dambkowski Buying and Selling Activity at Apogee Therapeutics

Apogee Therapeutics Company Overview

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs comprise APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $47.71

$45.51

$48.42

50 Day Range

MA: $50.60

$43.28

$61.12

2 Week Range

Now: $47.71

$24.88

$72.29

Volume

606,236 shs

Average Volume

504,083 shs

Market Capitalization

$2.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.3

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.

Carl Dambkowski Biography and Net Worth

What is Carl Dambkowski's net worth?

How old is Carl Dambkowski?

What is Carl Dambkowski's salary?

How do I contact Carl Dambkowski?

Has Carl Dambkowski been buying or selling shares of Apogee Therapeutics?

Who are Apogee Therapeutics' active insiders?

Are insiders buying or selling shares of Apogee Therapeutics?